Physician profile
Devan Marar
NPI 1114152717
$1,460.62
in general payments reported to CMS, 2019-2025
15 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $643 · 2020: $736 · 2021: $60.58 · 2022: $20.97.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Esperion Therapeutics, INC. | $518.00 | 2020 | |
| Amgen INC. | $199.19 | 2019-2020 | |
| Janssen Pharmaceuticals, INC | $159.06 | 2019-2020 | |
| Bayer Healthcare Pharmaceuticals INC. | $125.00 | 2019 | |
| Zoll Services LLC (A/K/A Zoll Lifecor Corp) | $95.21 | 2019 | |
| Boehringer Ingelheim Pharmaceuticals, INC. | $55.43 | 2019 | |
| Irhythm Technologies, INC. | $48.57 | 2019-2020 | |
| Cathworks, INC. | $46.94 | 2020 | |
| E.R. Squibb & Sons, L.L.C. | $45.83 | 2021 | |
| Pfizer INC. | $36.58 | 2019-2020 | |
| Astrazeneca Pharmaceuticals Lp | $36.50 | 2019-2020 | |
| Bardy Diagnostics, INC. | $35.72 | 2021-2022 | |
| Heartflow, INC. | $23.88 | 2019 | |
| Astellas Pharma US INC | $22.39 | 2019 | |
| Sanofi-Aventis U.S. LLC | $12.32 | 2020 |
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Devan Marar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.